Biotech Values

[Shengli]

Investors will of course make exactly the kinds of comparisons that you’re dismissing as irrelevant. By now, I think there’s enough data to say that Telaprevir is the clear frontrunner (#msg-54317080).

I think investors have already given VERTEX a 7 bil market cap in terms of MRK its not as big a deal as it is with VERTEX.That is the main reason they have not shown all of their data.VRTX needed money and loudly announced their data at every point in this process. You need to see the label . I am not saying they are irrelevant but in the real world things are not so black and white .

BTW your study to study comparisons are very unscientific.You continue to post these comparisons like its gospel.I know you are a smart man but what you are doing is not an accepted practice comparing non head to head studies.It is not allowed in the real world.